Valuation: Cellnovo

Market Cap 2.44M 2.09M 1.96M 1.79M 3.38M 232M 3.4M 23.22M 9M 117M 9.15M 8.95M 388M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.69M 10.04M 9.17M 17.3M 1.19B 17.38M 119M 46.03M 599M 46.78M 45.76M 1.99B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+2.13%-0.52%-35.14%+17.43% 16.95B
-0.15%+1.74% - - 13.8B
-7.85%+3.65%-22.63%-42.52% 10.01B
+0.19%-1.26%-13.62%+108.35% 7.52B
-2.43%-2.20%-55.79%+131.94% 3.67B
+1.15%-2.69%-44.48%-14.15% 2.33B
+2.62%-0.84%-42.04%-31.85% 1.85B
+0.30%+1.36%+35.15%+104.59% 1.68B
+0.87%+4.49%+13.20%+70.08% 1.47B
Average -0.44%+2.82%-20.67%+42.98% 5.93B
Weighted average by Cap. -0.76%+5.13%-27.10%+29.81%

Financials

2018 2019 *
Net sales 3.32M 2.85M 2.68M 2.44M 4.61M 317M 4.63M 31.67M 12.27M 160M 12.47M 12.2M 529M -
Net income -15.94M -13.68M -12.84M -11.73M -22.13M -1.52B -22.24M -152M -58.89M -767M -59.85M -58.55M -2.54B -
Net Debt 10.02M 8.6M 8.07M 7.37M 13.92M 956M 13.98M 95.55M 37.03M 482M 37.63M 36.81M 1.6B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock